PD-1-stimulated T cell subsets are transcriptionally and functionally distinct. 2021

Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032, USA.

Despite the obvious inhibitory outcome of PD-1 signaling, an additional series of functions are activated. We have observed that T cells stimulated through the T cell receptor (TCR) and PD-1 primarily do not proliferate; however, there is a population of cells that proliferates more than through TCR stimulation alone. In this study, we performed flow cytometry and RNA sequencing on individual populations of T cells and discovered that unlike naive T cells, which were inhibited following PD-1 ligation, T cells that proliferated more following PD-1 ligation were associated with effector and central memory phenotypes. We showed that these populations had different gene expression profiles following PD-1 ligation with PD-L1 compared to PD-L2. The presence of transcriptionally and functionally distinct T cell populations responsive to PD-1 ligation provides new insights into the biology of PD-1 and suggest the use of T cell subset-specific approaches to improve the clinical outcome of PD-1 blockade.

UI MeSH Term Description Entries

Related Publications

Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
June 2009, Journal of immunology (Baltimore, Md. : 1950),
Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
January 2021, Cell reports,
Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
July 2018, Nature medicine,
Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
April 2006, Journal of immunology (Baltimore, Md. : 1950),
Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
August 2022, American journal of respiratory cell and molecular biology,
Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
February 2008, Molecular immunology,
Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
July 2014, Nature immunology,
Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
November 1988, The Journal of experimental medicine,
Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
January 1987, Immunology today,
Shalom Lerrer, and Anna S Tocheva, and Shoiab Bukhari, and Kieran Adam, and Adam Mor
December 2005, The Journal of experimental medicine,
Copied contents to your clipboard!